SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-12-020790
Filing Date
2012-04-09
Accepted
2012-04-09 17:20:14
Documents
5
Period of Report
2012-05-25
Effectiveness Date
2012-04-09

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A v308896_def14a.htm DEF 14A 615454
2 GRAPHIC image_001.jpg GRAPHIC 2473
3 GRAPHIC image_002.jpg GRAPHIC 1297
4 GRAPHIC image_001.gif GRAPHIC 1971
5 GRAPHIC image_019.gif GRAPHIC 2727
  Complete submission text file 0001144204-12-020790.txt   628693
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33609 | Film No.: 12750252
SIC: 2834 Pharmaceutical Preparations